MedTrace Logo

A Study of Acetaminophen for Post Surgical Dental Pain

NCT04018612 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2022-03-29

Study results available
· View outcomes & findings →

Summary

To assess the safety, tolerability, analgesic, efficacy and pharmacokinetics of high dose acetaminophen relative to placebo and low dose acetaminophen relative to placebo over a 24 hour period in patient experiencing moderate to severe pain following the surgical removal of third molar.

Conditions

  • Pain, Postoperative
  • Dental Pain

Interventions

DRUG

Acetaminophen

Acetaminophen is an analgesic and antipyretic

OTHER

Placebo

Saline

Sponsors & Collaborators

  • Nevakar, Inc.

    lead INDUSTRY

Principal Investigators

  • Eric Lang, MD · Nevakar, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
17 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-04-25
Primary Completion
2019-07-26
Completion
2019-08-15
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04018612 on ClinicalTrials.gov